HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCA) and Zai Lab (ZLAB). HCA Healthcare (HCA) J.P...

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA) and Zai Lab (ZLAB)

Hall Chadwick Acquisition Corp. Class A ( ($HCAC) ) has released a notification of late filing. Hall Chadwick Acquisition Corp. Class A has filed a...

Hall Chadwick Acquisition Delays Quarterly SEC Filing

In a report released today, David Grossman from Stifel Nicolaus maintained a Hold rating on Health Catalyst, with a price target of $2.00. Grossman...

Health Catalyst (HCAT) Gets a Hold from Stifel Nicolaus

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dyne Therapeutics (DYN), Health Catalyst (HCAT) an...

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), Health Catalyst (HCAT) and Gain Therapeutics (GANX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Health Catalyst (HCAT) and Fisher & Paykel Healthcare Corporation...

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

An update from Hall Chadwick Acquisition Corp. Class A ( ($HCAC) ) is now available. On May 6, 2026, Hall Chadwick Acquisition Corp. announced that...

Hall Chadwick Director Resignation Prompts Routine Board Transition

HCA Healthcare ( ($HCA) ) just unveiled an announcement. On April 30, 2026, HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a $3 b...

HCA Healthcare Completes $3 Billion Senior Notes Offering

Huachen AI Parking Management Technology stock rallied on Thursday alongside heavy trading activity.


Why Is Huachen AI Parking Management Technology Stock (HCAI) Up Today?

Traders will find the most recent earnings reports, analysts updates, and economic data at TipRanks.


Morning News Wrap-Up, 4/30/26: Today’s Biggest Stock Market Stories!

HCA Healthcare ( ($HCA) ) has provided an update. HCA Healthcare, Inc. held its Annual Meeting of Stockholders on April 23, 2026, with more than 20...

HCA Healthcare Stockholders Reaffirm Board and Governance Structure

HCA Healthcare ( ($HCA) ) has shared an announcement. On April 27, 2026, HCA Healthcare said its subsidiary HCA Inc. had launched a proposed public...

HCA Healthcare Launches Note Offering to Refinance 2026 Debt

RBC Capital analyst Ben Hendrix maintained a Buy rating on HCA Healthcare yesterday and set a price target of $534.00. According to TipRanks, Hendr...

RBC Capital Keeps Their Buy Rating on HCA Healthcare (HCA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX), Resmed (RMD) and HCA Health...

Market Cap	$104.60B	P/E Ratio	13.00
52W High	$556.52	52W Low	$330.00
Div Yield	312.0%	Payout Ratio	10.0%
EPS Growth 3Y	13.9%	52W Position	26.9%
Overall Score	49	Value Score	65
Quality Score	57	Technical Score	27

EPS Current Est	$30.07	EPS Next Est	$32.98
EPS Growth Est	+9.7%	DPS Growth 3Y	8.7%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HCA	$391.04	-0.77%	399.11K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HCA	$391.04	-0.8%	399.11K
3
4
5
6

HCA

HCA

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get HCA Healthcare Inc. Data in Excel

Get HCA Healthcare Inc. Data in Excel